Cargando…
Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting
Trophoblast cell-surface antigen 2 (Trop-2) is a tumor-associated antigen that is connected with the development of various tumors and has been identified as a promising target for tumor immunotherapy. To date, the immunotherapy against Trop-2 mainly relies on the specific targeting by monoclonal an...
Autores principales: | Hu, Yaozhong, Wang, Yi, Lin, Jing, Wu, Sihao, Lv, Huan, Ji, Xuemeng, Wang, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316174/ https://www.ncbi.nlm.nih.gov/pubmed/35887287 http://dx.doi.org/10.3390/ijms23147942 |
Ejemplares similares
-
Identification of Serum Ferritin-Specific Nanobodies and Development towards a Diagnostic Immunoassay
por: Hu, Yaozhong, et al.
Publicado: (2022) -
Selection of Specific Nanobodies against Lupine Allergen Lup an 1 for Immunoassay Development
por: Hu, Yaozhong, et al.
Publicado: (2021) -
Function Characterization of Endogenous Plasmids in Cronobacter sakazakii and Identification of p-Coumaric Acid as Plasmid-Curing Agent
por: Ji, Xuemeng, et al.
Publicado: (2021) -
Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
por: Hu, Yaozhong, et al.
Publicado: (2017) -
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
por: Xu, Caili, et al.
Publicado: (2023)